1. Home
  2. EVH vs TECX Comparison

EVH vs TECX Comparison

Compare EVH & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EVH

Evolent Health Inc

N/A

Current Price

$3.39

Market Cap

667.0M

ML Signal

N/A

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$22.67

Market Cap

618.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
EVH
TECX
Founded
2011
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
667.0M
618.9M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
EVH
TECX
Price
$3.39
$22.67
Analyst Decision
Buy
Strong Buy
Analyst Count
14
9
Target Price
$5.75
★ $76.63
AVG Volume (30 Days)
★ 1.5M
187.3K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 40.70
EPS
★ N/A
N/A
Revenue
★ $907,957,000.00
N/A
Revenue This Year
$40.46
N/A
Revenue Next Year
$25.06
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.10
$14.62
52 Week High
$8.46
$39.53

Technical Indicators

Market Signals
Indicator
EVH
TECX
Relative Strength Index (RSI) 32.24 26.51
Support Level $2.53 $20.52
Resistance Level $3.68 $31.39
Average True Range (ATR) 0.18 1.43
MACD -0.02 -0.33
Stochastic Oscillator 3.12 7.02

Price Performance

Historical Comparison
EVH
TECX

About EVH Evolent Health Inc

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: